Intellectual Property - June 1, 2015
Fungal Nail Drug Gets Patent
An improved formulation of Moberg Pharma’s OTC product for the treatment of fungal nails, sold in the U.S. under the Kerasal Nail® brand, recently received a patent from the European Patent Office, according to Moberg. The patent expires in 2034. The corresponding U.S. patent was also granted earlier this spring and Moberg Pharma is pursuing […]
